FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

Panel Backs Moderna Covid Vaccine in Children

An FDA advisory committee votes unanimously (22 to 0) to recommend the agency grant Moderna an emergency use authorization for its Covid-19 vaccine in...

Human Drugs

ICH Draft Quality Risk Management Guidance

FDA publishes a draft International Council for Harmonization guidance on quality risk management with no new regulatory expectations.

Federal Register

Notice Corrected on Donor Eligibility Requirements

Federal Register notice: FDA corrects a 5/24 notice on a draft guidance being made available entitled "Blood Pressure and Pulse Donor Eligibility Requ...

Biologics

Pfizer, Moderna Vaccines Safe & Effective in Children: FDA

As FDA prepares for a 6/14-15 advisory committee meeting on pediatric Covid-19 vaccines, agency briefing documents find the Pfizer-BioNTech and Modern...

Federal Register

Comments Extended on Antimicrobial Drug Use

Federal Register notice: FDA extends the comment period for a 2/16 notice that requested comments on antimicrobial drug use practices in companion ani...

Human Drugs

FDA OKs Cancer Drugs Faster/Sooner Than EMA: Study

A new JAMA online study finds that FDA reviews and approves new oncology therapies much faster and sooner than the EMA.

Federal Register

Science Advisory Board Renewal

Federal Register notice: FDA renews its Science Advisory Board to the National Center for Toxicological Research for an additional two years.

Human Drugs

FDA Hits Rentschler Biopharma with 9-item 483

A February inspection at Rentschler Biopharmas German drug substance manufacturing plant results in a nine-item FDA-483 that cites significant GMP vio...

Human Drugs

Health Canada OKs ALS Drug Delayed at FDA

While FDA extends its own NDA review, Health Canada approves Amylyx Pharmaceuticals Albrioza (sodium phenylbutyrate and ursodoxicoltaurine) for treati...

Medical Devices

Ekso Bionics Exoskeleton Cleared for Multiple Sclerosis

FDA clears an Ekso Bionics Holdings 510(k) to market its EksoNR robotic exoskeleton for use with multiple sclerosis patients.